Head & Neck/Thyroid Cancers
Feature
Are oncologists ready to confront a second wave of COVID-19?
Conference Coverage
Clinical factors and treatment tied to COVID-19 mortality in cancer patients
Analyses of CCC19 data revealed factors linked to mortality in patients with COVID-19 and cancer.
Clinical Insights
The scope of under- and overtreatment in older adults with cancer
From the Journals
Cancer disparities: One of the most pressing public health issues
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Clinical Insights
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
From the Journals
Hair dye and cancer study ‘offers some reassurance’
Conference Coverage
VTE, sepsis risk increased among COVID-19 patients with cancer
Cancer patients had significantly lower hemoglobin levels, platelet counts, and red and white blood cell counts.
Guidelines
First guideline on NGS testing in cancer, from ESMO
From the Journals
Immunotherapy should not be withheld because of sex, age, or PS
From the Journals
Aspirin may accelerate cancer progression in older adults